Profit Pools in Pharma Industry

From branded generics, complex generics, specialty pharma, and innovative therapies, companies operate under very different business models.

Date - 13 Sep 2026

Time - 11:00 AM to 2:00 PM (Recording access)

Speakers - Kaustubh Roplekar (Founder, Alphawealth)

Manthan Rastogi (Co-Founder, Alphawealth)

Venue - Online (Google Meet)

In this session, we will break down the pharma industry by studying these business models through detailed company-level case studies.

5 Promising Pharma Business Models

We will deep-dive into 5 different pharma business models and understand their economics through detailed company case studies.

Each case study will help you understand:

→ The business model

→ Revenue & profit drivers

→ Industry structure

→ Competitive advantages

→ Growth triggers

→ Capital allocation

→ Key risks

→ Valuation framework

What will we cover?

We will go beyond the usual industry overview and understand:

The Key Takeaway

By the end of the session, you should be able to look at a pharma company and answer:

“Where does this company make its money, what drives its growth, and how sustainable are its profits?”

You will also walk away with a framework to analyse pharma companies and a clear understanding of 5 promising business models within the sector.